Owl Rock Capital Corp. II Files for Best-Efforts IPO (S&P Global)
Owl Rock Capital Corp II has filed a Form N-2 for an initial public offering of up to 150 million of its...
FS/KKR Plans to Merge Four Non-Traded BDCs in $9 Billion Combination (DIwire).
FS/KKR Advisor LLC, a partnership between FS Investments and KKR Credit Advisors LLC, have agreed to merge four non-traded business development companies...
Interview with Former UBS Managing Director and Now COO of StHealth Capital David Lessen.
While
not widely known, Wall Street’s Institutional Investment Managers and Registered
Investment Advisors (RIA’s) love using BDC
Investment Funds for their clients – to the...
StHealth Capital, Our #1 Ranked Emerging BDC Idea.
Newly Launched Medtech & Biotech BDC Seeking Pre-IPO Stage Investments.
This is easily one of the most exciting...
StHealth Private Equity Medtech Fund. Alternative Investment BDC.
StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with...
Former Tesla Foundation Vice Chairman Joins StHealth BDC.
St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...
Latest article
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
